This is an early access version, the complete PDF, HTML, and XML versions will be available soon.
Open AccessReview
Molecular Signature in Focal Cortical Dysplasia: A Systematic Review of RNA and Protein Data
1
Brno Epilepsy Centre, 1st Department of Neurology, St. Anne’s University Hospital, Faculty of Medicine, Masaryk University, 602 00 Brno, Czech Republic
2
Department of Experimental Biology, Faculty of Science, Masaryk University, Kotlářská 2, 602 00 Brno, Czech Republic
3
Behavioral and Social Neuroscience Research Group, CEITEC, Masaryk University, 625 00 Brno, Czech Republic
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2025, 26(20), 9909; https://doi.org/10.3390/ijms26209909 (registering DOI)
Submission received: 19 September 2025
/
Revised: 5 October 2025
/
Accepted: 7 October 2025
/
Published: 11 October 2025
Abstract
Focal cortical dysplasia (FCD) is a major cause of drug-resistant epilepsy, yet its molecular basis remains poorly understood. Numerous studies have analyzed RNA, protein, and microRNA alterations, but results are often inconsistent across subtypes and methodologies. To address this gap, we conducted a systematic review integrating transcriptomic, proteomic, and microRNA data from 117 human studies of FCD subtypes I–III. Differentially expressed factors were extracted, categorized by subtype, and analyzed using pathway enrichment and network approaches. Our integrative analysis revealed convergent dysregulation of neuroinflammatory, synaptic, cytoskeletal, and metabolic pathways across FCD subtypes. Consistently altered genes, including IL1B, TLR4, BDNF, HMGCR, and ROCK2, together with dysregulated microRNAs such as hsa-miR-21-5p, hsa-miR-155-5p, and hsa-miR-132-3p, were linked to PI3K–Akt–mTOR, Toll-like receptor, and GABAergic signaling, emphasizing shared pathogenic mechanisms. Importantly, we identified overlapping transcript–protein patterns and subtype-specific molecular profiles that may refine diagnosis and inform therapeutic strategies. This review provides the first cross-omics molecular framework of FCD, demonstrating how convergent pathways unify heterogeneous findings and offering a roadmap for biomarker discovery and targeted interventions.
Share and Cite
MDPI and ACS Style
Shakerzadeh, J.; Jaroušek, R.; Goliášová, Z.; Brázdil, M.
Molecular Signature in Focal Cortical Dysplasia: A Systematic Review of RNA and Protein Data. Int. J. Mol. Sci. 2025, 26, 9909.
https://doi.org/10.3390/ijms26209909
AMA Style
Shakerzadeh J, Jaroušek R, Goliášová Z, Brázdil M.
Molecular Signature in Focal Cortical Dysplasia: A Systematic Review of RNA and Protein Data. International Journal of Molecular Sciences. 2025; 26(20):9909.
https://doi.org/10.3390/ijms26209909
Chicago/Turabian Style
Shakerzadeh, Jalleh, Radim Jaroušek, Zita Goliášová, and Milan Brázdil.
2025. "Molecular Signature in Focal Cortical Dysplasia: A Systematic Review of RNA and Protein Data" International Journal of Molecular Sciences 26, no. 20: 9909.
https://doi.org/10.3390/ijms26209909
APA Style
Shakerzadeh, J., Jaroušek, R., Goliášová, Z., & Brázdil, M.
(2025). Molecular Signature in Focal Cortical Dysplasia: A Systematic Review of RNA and Protein Data. International Journal of Molecular Sciences, 26(20), 9909.
https://doi.org/10.3390/ijms26209909
Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details
here.
Article Metrics
Article metric data becomes available approximately 24 hours after publication online.